Clinical Trials

NCT02506933 | ACTIVE_NOT_RECRUITING | PHASE2
102 participants

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2015-12-21
Completion:
2018-01-25
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia in Remission
  • Chronic Lymphocytic Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Cytomegaloviral Infection
  • Hodgkin Lymphoma
  • Lymphadenopathy
  • Lymphoblastic Lymphoma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Myeloproliferative Neoplasm
  • Non-Hodgkin Lymphoma
Interventions
  • OTHER
  • BIOLOGICAL
NCT02417740 | RECRUITING
400 participants

Natural History of Noncirrhotic Portal Hypertension

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-28
Start Date:
2015-07-27
Completion:
2029-09-04
Conditions
  • Cystic Fibrosis
  • Immunologic Deficiency Syndrome
  • Turner Syndrome
  • Congenital Hepatic Fibrosis
  • Idiopathic Non-Cirrhotic Portal Hypertension
No Results Yet
NCT02208362 | ACTIVE_NOT_RECRUITING | PHASE1
65 participants

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2015-05-18
Completion:
2021-02-08
Conditions
  • Recurrent Glioblastoma
  • Recurrent Malignant Glioma
  • Recurrent WHO Grade II Glioma
  • Recurrent WHO Grade III Glioma
  • Refractory Glioblastoma
  • Refractory Malignant Glioma
  • Refractory WHO Grade II Glioma
  • Refractory WHO Grade III Glioma
Interventions
  • BIOLOGICAL
  • OTHER
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page